Terms: = Lung cancer AND Ki-67 AND Prognosis
353 results:
1. Construction of aptamer-siRNA chimera and glutamine modified carboxymethyl-β-cyclodextrin nanoparticles for the combination therapy against lung squamous cell carcinoma.
Hao Y; Yang J; Liu D; Zhang H; Ou T; Xiao L; Chen W
Biomed Pharmacother; 2024 May; 174():116506. PubMed ID: 38554525
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
3. SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.
Li S; Li Z; Huang L; Geng Z; Li F; Wu B; Sheng Y; Xu Y; Li B; Xu Y; Gu Z; Qi Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38275113
[TBL] [Abstract] [Full Text] [Related]
4. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
5. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
6. NRIP1 regulates cell proliferation in lung adenocarcinoma cells.
Watanabe F; Sato S; Hirose T; Endo M; Endo A; Ito H; Ohba K; Mori T; Takahashi K
J Biochem; 2024 Mar; 175(3):323-333. PubMed ID: 38102728
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
8. The clinicopathological features of BRG1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study.
Zhang J; Zhao R; Xu H; Dong L; Chen X
Ann Diagn Pathol; 2023 Dec; 67():152192. PubMed ID: 37639838
[TBL] [Abstract] [Full Text] [Related]
9. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956
[TBL] [Abstract] [Full Text] [Related]
10. COTE-1 promotes the proliferation and invasion of small cell lung cancer by regulating autophagy activity via the AMPK/mTOR signaling pathway.
Ma Y; Feng H; Wang Y; Hu L; Su X; Li N; Li X
Mol Cell Probes; 2023 Oct; 71():101918. PubMed ID: 37454876
[TBL] [Abstract] [Full Text] [Related]
11. Clinical characteristics and establishment of a 2-year-OS predictive model of EGFR mutation-positive patients with pleural invasion of lung adenocarcinoma.
Kong Q; Wang W; Wang Q; Yang Y; Chen G; Jiang T
Medicine (Baltimore); 2023 Jun; 102(26):e34184. PubMed ID: 37390230
[TBL] [Abstract] [Full Text] [Related]
12. The GR-SGK1-NDRG1 Pathway as a Predictor of Recurrence and prognosis in lung Adenocarcinoma After Radical Surgery.
Sasaki T; Nakamura Y; Hata S; Shimada H
Anticancer Res; 2023 Jul; 43(7):2965-2974. PubMed ID: 37351994
[TBL] [Abstract] [Full Text] [Related]
13. Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
Su YD; Zhao X; Ma R; Fu YB; Yang ZR; Wu HL; Yu Y; Yang R; Liang XL; Du XM; Chen Y; Li Y
Int J Hyperthermia; 2023; 40(1):2223374. PubMed ID: 37348853
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological Features and prognosis of lung Adenocarcinoma Patients With K-RAS Gene Mutation.
Sun D; Liu Y; Li P; Yang P; Yu G
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):406-413. PubMed ID: 37338109
[TBL] [Abstract] [Full Text] [Related]
15. Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China.
Zhang C; Wu H; Xu G; Xu Y; Ma W; Li Z; Zhang J
BMC Cancer; 2023 Jun; 23(1):506. PubMed ID: 37271825
[TBL] [Abstract] [Full Text] [Related]
16. Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract] [Full Text] [Related]
17. The clinicopathological significance of TOP2A expression in malignant peritoneal mesothelioma.
Du X; Li X; Zhang B; Hao Z; Gao Y; Jiang X; Yang Z; Chen Y
Ann Diagn Pathol; 2023 Aug; 65():152155. PubMed ID: 37172528
[TBL] [Abstract] [Full Text] [Related]
18. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
19. Renal angiomyolipoma with tumor thrombi: Clinical analysis of 18 cases in a single-center experience.
Wang T; Peng C; Ding X; Yang Y; Li J; Gu L; Wang B; Ma X
Urol Oncol; 2023 Jul; 41(7):328.e1-328.e8. PubMed ID: 37149431
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic role of CD74, CD10 and ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: a retrospective study.
Liang Y; Li C; Liu Y; Tian L; Yang D
BMC Cancer; 2023 May; 23(1):406. PubMed ID: 37147569
[TBL] [Abstract] [Full Text] [Related]
[Next]
